This announcement is a separate document:
容诚会计师事务所（特殊普通合伙）关于上海谊众药业股份有限公司2023年年报问询函回复的核查意见
Verification Opinion on the Reply to the Inquiry Letter of the 2023 Annual Report of Shanghai Yizhong Pharmaceutical Co., Ltd. by Rongcheng Certified Public Accountants (Special General Partnership)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated